Health & Medicine
-
AI in Healthcare: Accenture’s $150 Billion Savings Forecast and Market Projections to 2030
WASHINGTON, July 13 — A 2017 Accenture report projected that artificial intelligence could save the U.S. healthcare system $150 billion annually by…
-
HDT Bio Takes Glioblastoma Immunotherapy HDT-401 Toward a Phase 1 Trial at McGill
MONTREAL, July 13 — McGill University has announced a new partnership with HDT Bio, a biotechnology firm, to advance clinical trials for…
-
Dr. Colin Haile leads UH fight against fentanyl with vaccine
HOUSTON, July 13 — A vaccine candidate designed to neutralise fentanyl and its illicit chemical cousins has cleared an early scientific hurdle,…
-
Experimental vaccine shields mice from fentanyl and its chemical relatives
WASHINGTON — Inside a laboratory, a small group of mice is changing how researchers think about the opioid crisis. These animals, immunized…
-
Scripps Chemist Develops Vaccine To Train Immune System Against Fentanyl
LA JOLLA — Dr. Kim D. Janda is working on a vaccine that could change how the country fights the fentanyl crisis.…
-
Fentanyl Vaccines Move Toward Human Trials as Researchers Try to Stop Overdoses
WASHINGTON, July 13 — A fentanyl vaccine candidate remains in preclinical development, meaning it has not yet entered any human trials overseen…
-
Fine Particulate Matter Harms the Body and May Raise Dementia Risk
WASHINGTON — A growing body of evidence is drawing a clearer line between the air we breathe and the developing brains of…
-
Fentanyl Vaccine That Keeps the Drug Out of the Brain Is Set for Human Trials
ISLAMABAD, July 13 — A vaccine candidate designed to block fentanyl from reaching the brain has completed preclinical studies in animals, with…
-
Synthetic opioid deaths rose more than 23-fold from 2013 to 2023 before a 2024 drop
WASHINGTON, July 13 — The opioid crisis in the United States has reached unprecedented levels, with the Centers for Disease Control and…
-
Experimental Scripps vaccine trained mice’s immune systems to block fentanyl and its relatives
ISLAMABAD, July 13 — A novel vaccine candidate targeting fentanyl represents a fundamentally different approach from existing interventions for opioid overdose and…
-
Overdose deaths hit record high in 2021, fentanyl drives surge
WASHINGTON, July 13 — The opioid crisis in the United States has escalated dramatically over the past two decades, with synthetic opioids…
-
Vaccine Trains Immune System to Spot Broad Molecular Signature
SAN DIEGO, July 13 — A novel vaccine candidate developed at the Scripps Research Institute takes a clever, molecularly precise approach to…
-
University of Houston Fentanyl Vaccine Targets Drug’s Chemical Backbone
HOUSTON, July 13 — A novel vaccine candidate developed at the University of Houston is targeting the chemical backbone of fentanyl and…
-
Montana Researcher Jay Evans Develops Vaccine to Prevent Fentanyl Overdose
SEATTLE — Dr. Jay Evans has spent over 20 years building vaccines. The director of the Center for Translational Medicine at the…
-
Chinese Biotech Deals With Big Pharma Surge as Drugmakers Face Patent Cliff
BEIJING, July 13 — Cross-border deals for innovative drugs originating from China have reached a record US$110 billion in the first half…
-
Scripps Researchers Develop Experimental Vaccine to Keep Fentanyl and Variants From the Brain
SEATTLE — A team of researchers at the University of Washington School of Medicine has unveiled a vaccine candidate designed to neutralize…
-
Study Finds Wealth and Air Pollution Are the Strongest Predictors of State Autism Rates
ATLANTA, July 13 — A fresh analysis of autism prevalence across American states has turned up a correlation that researchers say merits…
-
HDT Bio Announces Canadian Glioblastoma Program With McGill University and The Neuro
SEATTLE, July 13 — A new type of RNA technology is moving from the lab toward a clinical trial for brain cancer.…
-
HDT Bio CEO Steve Reed Steers Seattle Vaccine Company Toward Cancer Treatments
SEATTLE, July 13 — Dr. Steve Reed, the CEO and co-founder of HDT Bio Corp, is leading the company’s shift from infectious…
-
Experimental vaccine protects mice against fentanyl and related opioids in new study
HOUSTON, July 13 — On the ground in the fight against the opioid crisis, researchers at the University of Houston and the…
-
Jammu and Kashmir reviews draft cancer care strategy to cut patient travel
SRINAGAR, July 13 — The Chief Secretary of Jammu and Kashmir, Atal Dulloo, chaired a high-level meeting here today to formulate a…
-
NYU AI Test Edges Out Oncotype DX in Predicting Breast Cancer Recurrence
NEW YORK, July 12 — A new AI tool from New York University may offer a cheaper alternative to genomic tests for…
-
Only 43 Antibiotics in Development as WHO Warns the Pipeline Falls Short
SINGAPORE, July 11 — For communities across Asia, the medicines that treat common infections are something many families take for granted. But…
-
Fleming’s 1928 Accidental Penicillin Discovery Revolutionized Medicine
LONDON, July 11 — In the corridors of medical history, few discoveries have altered the trajectory of human survival as profoundly as…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992